Starting Soliris (eculizumab)Your first 90 days with generalized myasthenia gravis: the steps, the dates and who to call
Trial Friendtrialfriend.com
How you take it
An infusion into a vein from a healthcare provider. Adults get 1 infusion a week for the first 5 weeks, then 1 every 2 weeks. It usually takes 35 minutes in adults and 1 to 4 hours in children, and staff watch you for at least 1 hour after.
Before your first dose
- A blood test that shows AChR antibodies, because Soliris is approved for myasthenia gravis only in people who have them.
- Meningitis shots, the ACWY shot and the MenB shot, at least 2 weeks before your first infusion. Your doctor checks whether older shots still count.
- If you cannot wait 2 weeks, the label says you get antibiotics and the shots as soon as possible.
- Tell your doctor if you have a fever or an infection. The label says Soliris is not started during a serious meningitis infection that has not cleared.
- For a child, the Medication Guide also calls for a pneumonia shot and a Hib shot, and the dose is set by the child's weight.
- Keep your Patient Safety Card with you during treatment and for 3 months after your last dose.
- Sign up with Alexion OneSource, the drugmaker's support program, for help with insurance and finding a place for the shots.
- After your insurance approves, a clinic or office in the safety program books your first 5 weekly visits.
The first 90 days
- 4 weeks beforeOneSource enrollment and the insurance check
- 3 weeks beforeVaccines done, or scheduled
- 2 weeks beforeMeningitis shots done, at least 2 weeks before your first infusion
- Week beforeApproval, then booking a certified site
- Day 1Day 1: first infusion (900mg for adults), then at least 1 hour of watching
- Day 8Day 8: second weekly infusion
- Day 15Day 15: third weekly infusion
- Day 22Day 22: fourth weekly infusion
- Day 29Day 29: fifth infusion, the first 1,200mg dose
- Day 43, then every 14 daysOne infusion every 2 weeks from here
- Day 90Three months in
Trial Friend, trialfriend.com. From the Soliris FDA label dated July 8, 2026 and the drugmaker's program, checked November 13, 2026. Not medical advice: Trial Friend is not a medical provider, and your doctor decides your dose and tests.